EIF5B and prostate cancer: Judging from the results, the expressions of PD-L1, both its mRNA and protein, were significantly inhibited in the eIF5B siRNA groups (P<0.01, Fig. 2A and B), suggesting that interference with eIF5B expression could inhibit PD-L1 expression in prostate cancer cells.